Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Med.

Sec. Ophthalmology

Volume 12 - 2025 | doi: 10.3389/fmed.2025.1605391

This article is part of the Research TopicUpdates in Ocular Therapeutics and Surgery - Volume IVView all 9 articles

Lutein-based dye vitrectomy for idiopathic epiretinal membrane: a pilot study

Provisionally accepted
Settimio  RossiSettimio Rossi1Carlo  GesualdoCarlo Gesualdo1*Michele  Della CorteMichele Della Corte1Antonio  Del GiudiceAntonio Del Giudice1Andrea  RosoliaAndrea Rosolia1Maria Consiglia  TrottaMaria Consiglia Trotta2Francesca  SimonelliFrancesca Simonelli1
  • 1Dipartimento Multidisciplinare di Specialità Medico-Chirurgiche e Odontoiatriche, Università della Campania Luigi Vanvitelli, Naples, Italy
  • 2Department of Experimental Medicine, University of Campania Luigi Vanvitelli, Naples, Campania, Italy

The final, formatted version of the article will be published soon.

The use of vital dyes is crucial to improve the visualization of vitreous and vitreoretinal interface during surgery. Here we evaluated the efficacy of a new lutein-based vital dye (LB-VD) for selective staining of the vitreous body and posterior hyaloid in patients undergoing 25 G vitrectomy for idiopathic epiretinal membrane (ERM). Methods: 18 patients who underwent ERM surgery assisted by LB-VD were retrospectively analyzed. The surgeon completed a post-operative satisfaction questionnaire to evaluate the vitreous staining. Data on best corrected visual acuity (BCVA), central retinal thickness (CRT), intraocular pressure (IOP), and fixation stability were collected at baseline, 4 months, and 6 months post-surgery. Results: LB-VD effectively stained the vitreous body and posterior hyaloid, facilitating key surgical maneuvers. Significant improvements were observed in BCVA and CRT at both 4-and 6-months after surgery. Specifically, BCVA improved from 0.60 ± 0.29 LogMAR to 0.33 ± 0.26 LogMAR at 4 months (p = 0.004) and to 0.32 ± 0.25 LogMAR at 6 months (p = 0.003). CRT decreased significantly from 429 (375-499) µm to 335 (254-375) µm at 4 months (p = 0.03) and to 323 (240-356) µm at 6 months (p = 0.01). Fixation stability improved in approximately 95% of patients at 6 months. No significant changes in IOP were noted. Discussion: LB-VD allowed clear visualization of the vitreous body and posterior hyaloid, facilitating key vitreoretinal surgical tasks. It provides an effective and safe alternative to traditional dyes currently used in vitreoretinal surgery.

Keywords: Chromovitrectomy, Vitreoretinal Surgery, vitreous body staining, posterior hyaloid detachment, Idiopathic epiretinal membrane

Received: 03 Apr 2025; Accepted: 26 May 2025.

Copyright: © 2025 Rossi, Gesualdo, Corte, Giudice, Rosolia, Trotta and Simonelli. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Carlo Gesualdo, Dipartimento Multidisciplinare di Specialità Medico-Chirurgiche e Odontoiatriche, Università della Campania Luigi Vanvitelli, Naples, Italy

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.